An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

doi:10.1084/jem.172.4.1193

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Ruddle, N. H.
	Articles by Clark, R. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Ruddle, N. H.
	Articles by Clark, R. B.


Social Bookmarking

	What's this?

ARTICLES

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

NH Ruddle, CM Bergman, KM McGrath, EG Lingenheld, ML Grunnet, SJ Padula and RB Clark
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06510.

Uncertainty regarding pathogenic mechanisms has been a major impediment to effective prevention and treatment for human neurologic diseases such as multiple sclerosis, tropical spastic paraparesis, and AIDS demyelinating disease. Here, we implicate lymphotoxin (LT) (tumor necrosis factor beta [TNF-beta]) and TNF-alpha in experimental allergic encephalomyelitis (EAE), a murine model of an autoimmune demyelinating disease. In this communication, we report that treatment of recipient mice with an antibody that neutralizes LT and TNF-alpha prevents transfer of clone-mediated EAE. LNC-8, a myelin basic protein-specific T cell line, produces high levels of LT and TNF-alpha after activation by concanavalin A, antibody to the CD-3 epsilon component of the T cell receptor, or myelin basic protein presented in the context of syngeneic spleen cells. LNC-8 cells transfer clinical signs of EAE. When LNC-8 recipient mice were also treated with TN3.19.12, a monoclonal antibody that neutralizes LT and TNF-alpha, the severity of the transferred EAE was reduced, while control antibodies did not alter the disease. The effect of anti-LT/TNF-alpha treatment was long lived and has been sustained for 5 mo. These findings suggest that LT and TNF-alpha and the T cells that produce them play an important role in EAE.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Sinha, S., Subramanian, S., Proctor, T. M., Kaler, L. J., Grafe, M., Dahan, R., Huan, J., Vandenbark, A. A., Burrows, G. G., Offner, H. (2007). A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS. J. Neurosci. 27: 12531-12539 [Abstract] [Full Text]
Roy, A., Liu, X., Pahan, K. (2007). Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via {alpha}5beta3 Integrin. J. Biol. Chem. 282: 32222-32232 [Abstract] [Full Text]
Ehrenstein, M. R., Mauri, C. (2007). If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine. J. Exp. Med. 204: 2249-2252 [Abstract] [Full Text]
Plant, S. R., Iocca, H. A., Wang, Y., Thrash, J. C., O'Connor, B. P., Arnett, H. A., Fu, Y.-X., Carson, M. J., Ting, J. P.-Y. (2007). Lymphotoxin {beta} Receptor (Lt{beta}R): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using Lt{beta}R-Ig Protein. J. Neurosci. 27: 7429-7437 [Abstract] [Full Text]
Khan, N., Ghousunnissa, S., Jegadeeswaran, S. M., Thiagarajan, D., Hasnain, S. E., Mukhopadhyay, S. (2007). Anti-B7-1/B7-2 antibody elicits innate-effector responses in macrophages through NF-{kappa}B-dependent pathway. Int Immunol 19: 477-486 [Abstract] [Full Text]
Herrmann, I., Kellert, M., Spreer, A., Gerber, J., Eiffert, H., Prinz, M., Nau, R. (2007). Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice. J Antimicrob Chemother 59: 74-79 [Abstract] [Full Text]
Aktas, O., Prozorovski, T., Zipp, F. (2006). Death Ligands and Autoimmune Demyelination. Neuroscientist 12: 305-316 [Abstract]
Friese, M. A., Montalban, X., Willcox, N., Bell, J. I., Martin, R., Fugger, L. (2006). The value of animal models for drug development in multiple sclerosis. Brain 129: 1940-1952 [Abstract] [Full Text]
Miyake, M., Sasaki, K., Ide, K., Matsukura, Y., Shijima, K., Fujiwara, D. (2006). Highly Oligomeric Procyanidins Ameliorate Experimental Autoimmune Encephalomyelitis via Suppression of Th1 Immunity. J. Immunol. 176: 5797-5804 [Abstract] [Full Text]
Dawes, R., Petrova, S., Liu, Z., Wraith, D., Beverley, P. C. L., Tchilian, E. Z. (2006). Combinations of CD45 Isoforms Are Crucial for Immune Function and Disease. J. Immunol. 176: 3417-3425 [Abstract] [Full Text]
Dasgupta, S., Jana, M., Liu, X., Pahan, K. (2005). Myelin Basic Protein-primed T Cells of Female but Not Male Mice Induce Nitric-oxide Synthase and Proinflammatory Cytokines in Microglia: IMPLICATIONS FOR GENDER BIAS IN MULTIPLE SCLEROSIS. J. Biol. Chem. 280: 32609-32617 [Abstract] [Full Text]
Kohm, A. P., Williams, J. S., Miller, S. D. (2004). Cutting Edge: Ligation of the Glucocorticoid-Induced TNF Receptor Enhances Autoreactive CD4+ T Cell Activation and Experimental Autoimmune Encephalomyelitis. J. Immunol. 172: 4686-4690 [Abstract] [Full Text]
Wu, W., Rinaldi, L., Fortner, K. A., Russell, J. Q., Tschopp, J., Irvin, C., Budd, R. C. (2004). Cellular FLIP Long Form-Transgenic Mice Manifest a Th2 Cytokine Bias and Enhanced Allergic Airway Inflammation. J. Immunol. 172: 4724-4732 [Abstract] [Full Text]
Lubick, K. J., Burgess, D. E. (2004). Purification and Analysis of a Phospholipase A2-Like Lytic Factor of Trichomonas vaginalis. Infect. Immun. 72: 1284-1290 [Abstract] [Full Text]
Nath, N., Giri, S., Prasad, R., Singh, A. K., Singh, I. (2004). Potential Targets of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor for Multiple Sclerosis Therapy. J. Immunol. 172: 1273-1286 [Abstract] [Full Text]
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., Platsoucas, C. D. (2004). Theiler's Virus Infection: a Model for Multiple Sclerosis. Clin. Microbiol. Rev. 17: 174-207 [Abstract] [Full Text]
Robertson, M., Liversidge, J., Forrester, J. V., Dick, A. D. (2003). Neutralizing Tumor Necrosis Factor-{alpha} Activity Suppresses Activation of Infiltrating Macrophages in Experimental Autoimmune Uveoretinitis. IOVS 44: 3034-3041 [Abstract] [Full Text]
Oliver, A. R., Lyon, G. M., Ruddle, N. H. (2003). Rat and Human Myelin Oligodendrocyte Glycoproteins Induce Experimental Autoimmune Encephalomyelitis by Different Mechanisms in C57BL/6 Mice. J. Immunol. 171: 462-468 [Abstract] [Full Text]
Dasgupta, S., Jana, M., Liu, X., Pahan, K. (2003). Role of Very-late Antigen-4 (VLA-4) in Myelin Basic Protein-primed T Cell Contact-induced Expression of Proinflammatory Cytokines in Microglial Cells. J. Biol. Chem. 278: 22424-22431 [Abstract] [Full Text]
Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R., Issazadeh-Navikas, S. (2003). IFN-{beta} Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis. J. Immunol. 170: 4776-4784 [Abstract] [Full Text]
Kuroki, M., Noguchi, Y., Shimono, M., Tomono, K., Tashiro, T., Obata, Y., Nakayama, E., Kohno, S. (2003). Repression of Bleomycin-Induced Pneumopathy by TNF. J. Immunol. 170: 567-574 [Abstract] [Full Text]
Murphy, C. A., Hoek, R. M., Wiekowski, M. T., Lira, S. A., Sedgwick, J. D. (2002). Interactions Between Hemopoietically Derived TNF and Central Nervous System-Resident Glial Chemokines Underlie Initiation of Autoimmune Inflammation in the Brain. J. Immunol. 169: 7054-7062 [Abstract] [Full Text]
Huber, S., Shi, C., Budd, R. C. (2002). {gamma}{delta} T Cells Promote a Th1 Response during Coxsackievirus B3 Infection In Vivo: Role of Fas and Fas Ligand. J. Virol. 76: 6487-6494 [Abstract] [Full Text]
Suresh, M., Lanier, G., Large, M. K., Whitmire, J. K., Altman, J. D., Ruddle, N. H., Ahmed, R. (2002). Role of Lymphotoxin {alpha} in T-Cell Responses during an Acute Viral Infection. J. Virol. 76: 3943-3951 [Abstract] [Full Text]
Tran, G. T., Carter, N., He, X. Y., Spicer, T. S., Plain, K. M., Nicolls, M., Hall, B. M., Hodgkinson, S. J. (2001). Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on Th1 cells that is augmented by IL-4. Int Immunol 13: 1109-1120 [Abstract] [Full Text]
Ito, A., Bebo, B. F. Jr., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A., Offner, H. (2001). Estrogen Treatment Down-Regulates TNF-{{alpha}} Production and Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Cytokine Knockout Mice. J. Immunol. 167: 542-552 [Abstract] [Full Text]
Beeton, C., Barbaria, J., Giraud, P., Devaux, J., Benoliel, A.-M., Gola, M., Sabatier, J. M., Bernard, D., Crest, M., Beraud, E. (2001). Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation. J. Immunol. 166: 936-944 [Abstract] [Full Text]
Subramanian, S., Bourdette, D. N., Corless, C., Vandenbark, A. A., Offner, H., Jones, R. E. (2001). T Lymphocytes Promote the Development of Bone Marrow-Derived APC in the Central Nervous System. J. Immunol. 166: 370-376 [Abstract] [Full Text]
Selmaj, K. W (2000). Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system. Ann Rheum Dis 59: i94-102 [Full Text]
Probert, L., Eugster, H.-P., Akassoglou, K., Bauer, J., Frei, K., Lassmann, H., Fontana, A. (2000). TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 123: 2005-2019 [Abstract] [Full Text]
Kallmann, B. A., Hummel, V., Lindenlaub, T., Ruprecht, K., Toyka, K. V., Rieckmann, P. (2000). Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1. Brain 123: 687-697 [Abstract] [Full Text]
Croxford, J. L., Triantaphyllopoulos, K. A., Neve, R. M., Feldmann, M., Chernajovsky, Y., Baker, D. (2000). Gene Therapy for Chronic Relapsing Experimental Allergic Encephalomyelitis Using Cells Expressing a Novel Soluble p75 Dimeric TNF Receptor. J. Immunol. 164: 2776-2781 [Abstract] [Full Text]
Juedes, A. E., Hjelmstrom, P., Bergman, C. M., Neild, A. L., Ruddle, N. H. (2000). Kinetics and Cellular Origin of Cytokines in the Central Nervous System: Insight into Mechanisms of Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis. J. Immunol. 164: 419-426 [Abstract] [Full Text]
Klimstra, W. B., Ryman, K. D., Bernard, K. A., Nguyen, K. B., Biron, C. A., Johnston, R. E. (1999). Infection of Neonatal Mice with Sindbis Virus Results in a Systemic Inflammatory Response Syndrome. J. Virol. 73: 10387-10398 [Abstract] [Full Text]
Bourrie, B., Bribes, E., Esclangon, M., Garcia, L., Marchand, J., Thomas, C., Maffrand, J.-P., Casellas, P. (1999). The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: Implications for multiple sclerosis treatment. Proc. Natl. Acad. Sci. USA 96: 12855-12859 [Abstract] [Full Text]
Jurewicz, A. M., Walczak, A. K., Selmaj, K. W. (1999). Shedding of TNF receptors in multiple sclerosis patients. Neurology 53: 1409-1409 [Abstract] [Full Text]
Artis, D., Humphreys, N. E., Bancroft, A. J., Rothwell, N. J., Potten, C. S., Grencis, R. K. (1999). Tumor Necrosis Factor {alpha} Is a Critical Component of Interleukin 13�mediated Protective T Helper Cell Type 2 Responses during Helminth Infection. J. Exp. Med. 190: 953-962 [Abstract] [Full Text]
Arnason, (1999). TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study. Neurology 53: 457-457 [Abstract] [Full Text]
Perrin, P. J., June, C. H., Maldonado, J. H., Ratts, R. B., Racke, M. K. (1999). Blockade of CD28 During In Vitro Activation of Encephalitogenic T Cells or After Disease Onset Ameliorates Experimental Autoimmune Encephalomyelitis. J. Immunol. 163: 1704-1710 [Abstract] [Full Text]
Assa, A., Watemberg, N., Bujanover, Y., Lerman-Sagie, T. (1999). Demyelinative Brainstem Encephalitis Responsive to Intravenous Immunoglobulin Therapy. Pediatrics 104: 301-303 [Abstract] [Full Text]
Dittel, B. N., Merchant, R. M., Janeway, C. A. Jr. (1999). Evidence for Fas-Dependent and Fas-Independent Mechanisms in the Pathogenesis of Experimental Autoimmune Encephalomyelitis. J. Immunol. 162: 6392-6400 [Abstract] [Full Text]
Yoshikawa, M., Suzumura, A., Tamaru, T., Takayanagi, T., Sawada, M. (1999). Effects of phosphodiesterase inhibitors on cytokine production by microglia. Mult Scler 5: 126-133 [Abstract]
BUCCELLATO, F. R., MILOSO, M., BRAGA, M., NICOLINI, G., MORABITO, A., PRAVETTONI, G., TREDICI, G., SCALABRINO, G. (1999). Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-{alpha}-mediated. FASEB J. 13: 297-304 [Abstract] [Full Text]
Gramaglia, I., Mauri, D. N., Miner, K. T., Ware, C. F., Croft, M. (1999). Lymphotoxin {alpha}{beta} Is Expressed on Recently Activated Naive and Th1-Like CD4 Cells but Is Down-Regulated by IL-4 During Th2 Differentiation. J. Immunol. 162: 1333-1338 [Abstract] [Full Text]
Constantin, G., Laudanna, C., Brocke, S., Butcher, E. C. (1999). Inhibition of Experimental Autoimmune Encephalomyelitis by a Tyrosine Kinase Inhibitor. J. Immunol. 162: 1144-1149 [Abstract] [Full Text]
Cuff, C. A., Schwartz, J., Bergman, C. M., Russell, K. S., Bender, J. R., Ruddle, N. H. (1998). Lymphotoxin {alpha}3 Induces Chemokines and Adhesion Molecules: Insight into the Role of LT{alpha} in Inflammation and Lymphoid Organ Development. J. Immunol. 161: 6853-6860 [Abstract] [Full Text]
Bright, J. J., Du, C., Coon, M., Sriram, S., Klaus, S. J. (1998). Prevention of Experimental Allergic Encephalomyelitis via Inhibition of IL-12 Signaling and IL-12-Mediated Th1 Differentiation: An Effect of the Novel Anti-Inflammatory Drug Lisofylline. J. Immunol. 161: 7015-7022 [Abstract] [Full Text]
Wildbaum, G., Youssef, S., Grabie, N., Karin, N. (1998). Neutralizing Antibodies to IFN-{gamma}-Inducing Factor Prevent Experimental Autoimmune Encephalomyelitis. J. Immunol. 161: 6368-6374 [Abstract] [Full Text]
Agnello, D., Bertini, R., Sacco, S., Meazza, C., Villa, P., Ghezzi, P. (1998). Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am. J. Physiol. Endocrinol. Metab. 275: E757-E762 [Abstract] [Full Text]
Begolka, W. S., Vanderlugt, C. L., Rahbe, S. M., Miller, S. D. (1998). Differential Expression of Inflammatory Cytokines Parallels Progression of Central Nervous System Pathology in Two Clinically Distinct Models of Multiple Sclerosis. J. Immunol. 161: 4437-4446 [Abstract] [Full Text]
Stalder, A. K., Carson, M. J., Pagenstecher, A., Asensio, V. C., Kincaid, C., Benedict, M., Powell, H. C., Masliah, E., Campbell, I. L. (1998). Late-Onset Chronic Inflammatory Encephalopathy in Immune-Competent and Severe Combined Immune-Deficient (SCID) Mice with Astrocyte-Targeted Expression of Tumor Necrosis Factor. Am. J. Pathol. 153: 767-783 [Abstract] [Full Text]
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., Probert, L. (1998). Oligodendrocyte Apoptosis and Primary Demyelination Induced by Local TNF/p55TNF Receptor Signaling in the Central Nervous System of Transgenic Mice : Models for Multiple Sclerosis with Primary Oligodendrogliopathy. Am. J. Pathol. 153: 801-813 [Abstract] [Full Text]
Rajan, A. J., Klein, J. D. S., Brosnan, C. F. (1998). The Effect of {gamma}{delta} T Cell Depletion on Cytokine Gene Expression in Experimental Allergic Encephalomyelitis. J. Immunol. 160: 5955-5962 [Abstract] [Full Text]
Cantorna, M. T., Woodward, W. D., Hayes, C. E., DeLuca, H. F. (1998). 1,25-Dihydroxyvitamin D3 Is a Positive Regulator for the Two Anti-Encephalitogenic Cytokines TGF-{beta}1 and IL-4. J. Immunol. 160: 5314-5319 [Abstract] [Full Text]
Martiney, J. A., Rajan, A. J., Charles, P. C., Cerami, A., Ulrich, P. C., Macphail, S., Tracey, K. J., Brosnan, C. F. (1998). Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by CNI-1493, a Macrophage-Deactivating Agent. J. Immunol. 160: 5588-5595 [Abstract] [Full Text]
Croxford, J. L., Triantaphyllopoulos, K., Podhajcer, O. L., Feldmann, M., Baker, D., Chernajovsky, Y. (1998). Cytokine Gene Therapy in Experimental Allergic Encephalomyelitis by Injection of Plasmid DNA-Cationic Liposome Complex into the Central Nervous System. J. Immunol. 160: 5181-5187 [Abstract] [Full Text]
Karin, N., Binah, O., Grabie, N., Mitchell, D. J., Felzen, B., Solomon, M. D., Conlon, P., Gaur, A., Ling, N., Steinman, L. (1998). Short Peptide-Based Tolerogens Without Self-Antigenic or Pathogenic Activity Reverse Autoimmune Disease. J. Immunol. 160: 5188-5194 [Abstract] [Full Text]
Segal, B. M., Dwyer, B. K., Shevach, E. M. (1998). An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease. J. Exp. Med. 187: 537-546 [Abstract] [Full Text]
Korner, H., Riminton, D. S., Strickland, D. H., Lemckert, F. A., Pollard, J. D., Sedgwick, J. D. (1997). Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting. J. Exp. Med. 186: 1585-1590 [Abstract] [Full Text]
Suen, W. E., Bergman, C. M., Hjelmstrom, P., Ruddle, N. H. (1997). A Critical Role for Lymphotoxin in Experimental Allergic Encephalomyelitis. J. Exp. Med. 186: 1233-1240 [Abstract] [Full Text]
Diamond, D. J., York, J., Sun, J.-Y., Wright, C. L., Forman, S. J. (1997). Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection. Blood 90: 1751-1767 [Abstract] [Full Text]
Lafaille, J. J., Keere, F. V. d., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., Tonegawa, S. (1997). Myelin Basic Protein-specific T Helper 2�(Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the Disease. J. Exp. Med. 186: 307-312 [Abstract] [Full Text]
Steinman, L. (1997). Some Misconceptions about Understanding Autoimmunity through Experiments with Knockouts. J. Exp. Med. 185: 2039-2041 [Full Text]
Frei, K., Eugster, H.-P., Bopst, M., Constantinescu, C. S., Lavi, E., Fontana, A. (1997). Tumor Necrosis Factor alpha �and Lymphotoxin alpha �Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis. J. Exp. Med. 185: 2177-2182 [Abstract] [Full Text]
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., Feuerstein, G. Z. (1997). Tumor Necrosis Factor-{alpha} : A Mediator of Focal Ischemic Brain Injury. Stroke 28: 1233-1244 [Abstract] [Full Text]
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., McDevitt, H. O. (1997). Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling. J. Exp. Med. 185: 1573-1584 [Abstract] [Full Text]
Bachmaier, K., Pummerer, C., Kozieradzki, I., Pfeffer, K., Mak, T. W., Neu, N., Penninger, J. M. (1997). Low-Molecular-Weight Tumor Necrosis Factor Receptor p55 Controls Induction of Autoimmune Heart Disease. Circulation 95: 655-661 [Abstract] [Full Text]
Conboy, I. M., DeKruyff, R. H., Tate, K. M., Cao, Z. A., Moore, T. A., Umetsu, D. T., Jones, P. P. (1997). Novel Genetic Regulation of �T Helper 1�(Th1)/Th2 Cytokine Production and Encephalitogenicity in Inbred Mouse Strains. J. Exp. Med. 185: 439-452 [Abstract] [Full Text]
De Togni, P, Goellner, J, Ruddle, N., Streeter, P., Fick, A, Mariathasan, S, Smith, S., Carlson, R, Shornick, L., Strauss-Schoenberger, J, et, al. (1994). Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707 [Abstract]
Louis, J., Magal, E, Takayama, S, Varon, S (1993). CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259: 689-692 [Abstract]
Takano, R., Hisahara, S., Namikawa, K., Kiyama, H., Okano, H., Miura, M. (2000). Nerve Growth Factor Protects Oligodendrocytes from Tumor Necrosis Factor-alpha -induced Injury through Akt-mediated Signaling Mechanisms. J. Biol. Chem. 275: 16360-16365 [Abstract] [Full Text]
Girvin, A. M., Gordon, K. B., Welsh, C. J., Clipstone, N. A., Miller, S. D. (2002). Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood 99: 3692-3701 [Abstract] [Full Text]